135065-72-4

Basic information

• Product Name: (S)-N-benzyl-3-chloroacetamidopropane-1,2-diol
• Synonyms: (S)-N-benzyl-3-chloroacetamidopropane-1,2-diol
• CAS NO: 135065-72-4
• Molecular Weight: 257.717
• Mol File: 135065-72-4.mol

Chemical Properties

• CAS DataBase Reference: (S)-N-benzyl-3-chloroacetamidopropane-1,2-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N-benzyl-3-chloroacetamidopropane-1,2-diol(135065-72-4)
• EPA Substance Registry System: (S)-N-benzyl-3-chloroacetamidopropane-1,2-diol(135065-72-4)

Safety Data

• Hazardous Substances Data: 135065-72-4(Hazardous Substances Data)

Upstream product

• 79-04-9 chloroacetyl chloride 
• 100-46-9 benzylamine 
• 1707-77-3 1,2:5,6-di-O-isopropylidene-D-mannitol 
• 148638-81-7 Methanesulfonic acid (S)-2-(benzyl-tert-butoxycarbonyl-amino)-1-methanesulfonyloxymethyl-ethyl ester 
• 148638-82-8 Acetic acid (R)-3-benzyl-2-oxo-oxazolidin-5-ylmethyl ester 
• 148638-77-1 N-Benzyl-2-chloro-N-((S)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl)-acetamide 
• 148638-79-3 N-benzyl-N-(tert-butoxycarbonyl)-N-amine 
• 148638-80-6 N-benzyl-N-(tert-butoxycarbonyl)-N-<2(S),3-dihydroxypropyl>amine 
• 109208-40-4 N-benzyl-N-amine 

Downstream Products

• 148638-78-2 (S)-4-Benzyl-6-hydroxymethyl-morpholin-3-one 
• 135065-73-5 (S)-N-benzyl-3-chloroacetamido-1-triphenylmethoxy-2-propanol 
• 135065-62-2 (S)-4-tert-butoxycarbonyl-2-p-nitrobenzenesulfonyloxymethylmorpholine 
• 148638-76-0 tert-butyl (2S)-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)morpholine-4-carboxylate 
• 135065-76-8 tert-butyl (2S)-2-(hydroxymethyl)morpholine-4-carboxylate 
• 132073-82-6 (S)-4-Benzyl-2-(hydroxymethyl)morpholine 
• 132073-83-7 (S)-morpholin-2-ylmethanol 

Relevant articles and documents

FACILE SYNTHESIS OF OPTICALLY ACTIVE SULFONATES OF 4-tert-BUTOXYCARBONYL-2-HYDROXYMETHYLMORPHOLINE

Optically active sulfonates of 4-tert-butoxycarbonyl-2-hydroxymethylmorpholine were prepared from 1,2:5,6-di-O-D-mannitol by practical procedures.These compounds are versatile intermediates for optically active isomers of a number of neuropharmacologicall

Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders

Compounds of formula (I): [in which: A is a group of formula (II) or (III): R1, R2 and R3 are hydrogen, lower alkyl or halogen; R4 is hydrogen, lower alkyl or aralkyl; R5 and R6 are hydrogen or lower alkyl; R7 a